News
Archive
Parker Aerospace and DUST Identity launch Lockheed Martin F-35 into digital space
Ventyx Biosciences announces positive topline Phase I data for its peripheral NLRP3 inhibitor VTX2735
Cambridge Epigenetix names Peter Fromen as Chief Executive Officer
Phase Four and Impulse Space to collaborate on multi-mode propulsion
Vascular Therapies completes $25 million private financing
Introducing Avari Wireless, a state-of-the-art designer & manufacturer of public safety DAS
Back To News

October 17, 2017
Dezima
Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.